ID   NRAM1_HUMAN             Reviewed;         550 AA.
AC   P49279; C0H5Y3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   28-JUN-2023, entry version 187.
DE   RecName: Full=Natural resistance-associated macrophage protein 1;
DE            Short=NRAMP 1;
DE   AltName: Full=Solute carrier family 11 member 1;
GN   Name=SLC11A1; Synonyms=LSH, NRAMP, NRAMP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=7964458; DOI=10.1084/jem.180.5.1741;
RA   Cellier M., Govoni G., Vidal S., Kwan T., Groulx N., Liu J., Sanchez F.,
RA   Skamene E., Schurr E., Gros P.;
RT   "Human natural resistance-associated macrophage protein: cDNA cloning,
RT   chromosomal mapping, genomic organization, and tissue-specific
RT   expression.";
RL   J. Exp. Med. 180:1741-1752(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=8537108; DOI=10.1016/0165-2478(95)00070-l;
RA   Kishi F., Nobumoto M.;
RT   "Identification of natural resistance-associated macrophage protein in
RT   peripheral blood lymphocytes.";
RL   Immunol. Lett. 47:93-96(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10967134; DOI=10.1007/s003350010151;
RA   Marquet S., Lepage P., Hudson T.J., Musser J.M., Schurr E.;
RT   "Complete nucleotide sequence and genomic structure of the human NRAMP1
RT   gene region on chromosome region 2q35.";
RL   Mamm. Genome 11:755-762(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-550 (ISOFORM 1).
RX   PubMed=7980580; DOI=10.1006/bbrc.1994.2572;
RA   Kishi F.;
RT   "Isolation and characterization of human Nramp cDNA.";
RL   Biochem. Biophys. Res. Commun. 204:1074-1080(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8529098; DOI=10.1007/bf03401567;
RA   Blackwell J.M., Barton C.H., White J.K., Searle S., Baker A.-M.,
RA   Williams H., Shaw M.-A.;
RT   "Genomic organization and sequence of the human NRAMP gene: identification
RT   and mapping of a promoter region polymorphism.";
RL   Mol. Med. 1:194-205(1995).
RN   [9]
RP   VARIANTS VAL-318 AND ASN-543.
RX   PubMed=7717395;
RA   Liu J., Fujiwara T.M., Buu N.T., Sanchez F.O., Cellier M., Paradis A.J.,
RA   Frappier D., Skamene E., Gros P., Morgan K., Schurr E.;
RT   "Identification of polymorphisms and sequence variants in the human
RT   homologue of the mouse natural resistance-associated macrophage protein
RT   gene.";
RL   Am. J. Hum. Genet. 56:845-853(1995).
RN   [10]
RP   INVOLVEMENT IN MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY.
RX   PubMed=16103355; DOI=10.1073/pnas.0503368102;
RA   Malik S., Abel L., Tooker H., Poon A., Simkin L., Girard M., Adams G.J.,
RA   Starke J.R., Smith K.C., Graviss E.A., Musser J.M., Schurr E.;
RT   "Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12183-12188(2005).
RN   [11]
RP   ASSOCIATION OF VARIANT ASN-543 WITH SUSCEPTIBILITY TO INFECTION WITH
RP   MYCOBACTERIUM ULCERANS.
RX   PubMed=16395392; DOI=10.1038/sj.gene.6364281;
RA   Stienstra Y., van der Werf T.S., Oosterom E., Nolte I.M.,
RA   van der Graaf W.T.A., Etuaful S., Raghunathan P.L., Whitney E.A.S.,
RA   Ampadu E.O., Asamoa K., Klutse E.Y., te Meerman G.J., Tappero J.W.,
RA   Ashford D.A., van der Steege G.;
RT   "Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1)
RT   D543N polymorphism.";
RL   Genes Immun. 7:185-189(2006).
CC   -!- FUNCTION: Divalent transition metal (iron and manganese) transporter
CC       involved in iron metabolism and host resistance to certain pathogens.
CC       Macrophage-specific membrane transport function. Controls natural
CC       resistance to infection with intracellular parasites. Pathogen
CC       resistance involves sequestration of Fe(2+) and Mn(2+), cofactors of
CC       both prokaryotic and eukaryotic catalases and superoxide dismutases,
CC       not only to protect the macrophage against its own generation of
CC       reactive oxygen species, but to deny the cations to the pathogen for
CC       synthesis of its protective enzymes.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49279-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49279-2; Sequence=VSP_047875, VSP_047876;
CC   -!- TISSUE SPECIFICITY: Macrophages; peripheral blood leukocytes, lung,
CC       spleen and liver.
CC   -!- INDUCTION: In response to lymphokine or bacterial products.
CC   -!- POLYMORPHISM: Genetic variation in SLC11A1 is associated with
CC       susceptibility to infection with Mycobacterium ulcerans [MIM:610446].
CC   -!- POLYMORPHISM: Genetic variations in SLC11A1 determine Mycobacterium
CC       tuberculosis susceptibility [MIM:607948].
CC   -!- SIMILARITY: Belongs to the NRAMP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L32185; AAA57521.1; -; mRNA.
DR   EMBL; L38593; AAA57557.1; -; Genomic_DNA.
DR   EMBL; L38592; AAA57557.1; JOINED; Genomic_DNA.
DR   EMBL; AF229163; AAG15405.1; -; Genomic_DNA.
DR   EMBL; AC021016; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471063; EAW70611.1; -; Genomic_DNA.
DR   EMBL; BC071165; AAH71165.1; -; mRNA.
DR   EMBL; D50402; BAA08907.1; -; mRNA.
DR   EMBL; D50403; BAA08908.1; -; mRNA.
DR   EMBL; D38171; BAA07370.1; -; mRNA.
DR   EMBL; X82015; CAA57541.1; -; Genomic_DNA.
DR   CCDS; CCDS2415.1; -. [P49279-1]
DR   PIR; I55679; I55679.
DR   PIR; JC4095; JC4095.
DR   RefSeq; NP_000569.3; NM_000578.3. [P49279-1]
DR   RefSeq; XP_005246850.1; XM_005246793.3.
DR   RefSeq; XP_005246851.1; XM_005246794.3.
DR   RefSeq; XP_006712772.1; XM_006712709.3.
DR   RefSeq; XP_006712773.1; XM_006712710.3.
DR   RefSeq; XP_016860255.1; XM_017004766.1.
DR   AlphaFoldDB; P49279; -.
DR   SMR; P49279; -.
DR   STRING; 9606.ENSP00000233202; -.
DR   BindingDB; P49279; -.
DR   ChEMBL; CHEMBL2052040; -.
DR   TCDB; 2.A.55.2.3; the metal ion (mn(2+)-iron) transporter (nramp) family.
DR   GlyCosmos; P49279; 2 sites, No reported glycans.
DR   GlyGen; P49279; 2 sites.
DR   iPTMnet; P49279; -.
DR   PhosphoSitePlus; P49279; -.
DR   BioMuta; SLC11A1; -.
DR   DMDM; 1352521; -.
DR   MassIVE; P49279; -.
DR   PaxDb; P49279; -.
DR   PeptideAtlas; P49279; -.
DR   ProteomicsDB; 55978; -. [P49279-1]
DR   ProteomicsDB; 7572; -.
DR   Antibodypedia; 3997; 200 antibodies from 27 providers.
DR   DNASU; 6556; -.
DR   Ensembl; ENST00000233202.11; ENSP00000233202.6; ENSG00000018280.17. [P49279-1]
DR   GeneID; 6556; -.
DR   KEGG; hsa:6556; -.
DR   MANE-Select; ENST00000233202.11; ENSP00000233202.6; NM_000578.4; NP_000569.3.
DR   UCSC; uc002vhv.3; human. [P49279-1]
DR   AGR; HGNC:10907; -.
DR   CTD; 6556; -.
DR   DisGeNET; 6556; -.
DR   GeneCards; SLC11A1; -.
DR   HGNC; HGNC:10907; SLC11A1.
DR   HPA; ENSG00000018280; Tissue enhanced (lung, lymphoid tissue).
DR   MalaCards; SLC11A1; -.
DR   MIM; 600266; gene.
DR   MIM; 607948; phenotype.
DR   MIM; 610446; phenotype.
DR   neXtProt; NX_P49279; -.
DR   OpenTargets; ENSG00000018280; -.
DR   Orphanet; 586; Cystic fibrosis.
DR   Orphanet; 3389; Tuberculosis.
DR   PharmGKB; PA319; -.
DR   VEuPathDB; HostDB:ENSG00000018280; -.
DR   eggNOG; KOG1291; Eukaryota.
DR   GeneTree; ENSGT00940000160799; -.
DR   HOGENOM; CLU_020088_5_2_1; -.
DR   InParanoid; P49279; -.
DR   OMA; STYLVWT; -.
DR   OrthoDB; 1093299at2759; -.
DR   PhylomeDB; P49279; -.
DR   TreeFam; TF315185; -.
DR   PathwayCommons; P49279; -.
DR   Reactome; R-HSA-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-HSA-425410; Metal ion SLC transporters.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6803544; Ion influx/efflux at host-pathogen interface.
DR   SignaLink; P49279; -.
DR   SIGNOR; P49279; -.
DR   BioGRID-ORCS; 6556; 10 hits in 1147 CRISPR screens.
DR   ChiTaRS; SLC11A1; human.
DR   GeneWiki; SLC11A1; -.
DR   GenomeRNAi; 6556; -.
DR   Pharos; P49279; Tbio.
DR   PRO; PR:P49279; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P49279; protein.
DR   Bgee; ENSG00000018280; Expressed in right lung and 134 other tissues.
DR   ExpressionAtlas; P49279; baseline and differential.
DR   Genevisible; P49279; HS.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005770; C:late endosome; ISS:BHF-UCL.
DR   GO; GO:0031902; C:late endosome membrane; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; ISS:BHF-UCL.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IMP:BHF-UCL.
DR   GO; GO:0070821; C:tertiary granule membrane; IDA:BHF-UCL.
DR   GO; GO:0015086; F:cadmium ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005381; F:iron ion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005384; F:manganese ion transmembrane transporter activity; ISS:BHF-UCL.
DR   GO; GO:0051139; F:metal cation:proton antiporter activity; IGI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0046915; F:transition metal ion transmembrane transporter activity; IGI:BHF-UCL.
DR   GO; GO:0032147; P:activation of protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0048002; P:antigen processing and presentation of peptide antigen; ISS:BHF-UCL.
DR   GO; GO:0019730; P:antimicrobial humoral response; TAS:Reactome.
DR   GO; GO:0070574; P:cadmium ion transmembrane transport; IGI:BHF-UCL.
DR   GO; GO:0045454; P:cell redox homeostasis; TAS:Reactome.
DR   GO; GO:0098849; P:cellular detoxification of cadmium ion; IGI:BHF-UCL.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:BHF-UCL.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISS:BHF-UCL.
DR   GO; GO:0042832; P:defense response to protozoan; ISS:BHF-UCL.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; IMP:BHF-UCL.
DR   GO; GO:0006826; P:iron ion transport; IMP:BHF-UCL.
DR   GO; GO:1903826; P:L-arginine transmembrane transport; IEA:Ensembl.
DR   GO; GO:0042116; P:macrophage activation; ISS:BHF-UCL.
DR   GO; GO:0006828; P:manganese ion transport; ISS:BHF-UCL.
DR   GO; GO:0030001; P:metal ion transport; ISS:BHF-UCL.
DR   GO; GO:0045342; P:MHC class II biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0048255; P:mRNA stabilization; ISS:BHF-UCL.
DR   GO; GO:0060586; P:multicellular organismal-level iron ion homeostasis; ISS:BHF-UCL.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISS:BHF-UCL.
DR   GO; GO:0015707; P:nitrite transport; ISS:BHF-UCL.
DR   GO; GO:0006909; P:phagocytosis; ISS:BHF-UCL.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:BHF-UCL.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISS:BHF-UCL.
DR   GO; GO:0002827; P:positive regulation of T-helper 1 type immune response; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISS:ARUK-UCL.
DR   GO; GO:0045730; P:respiratory burst; ISS:BHF-UCL.
DR   GO; GO:0009617; P:response to bacterium; IDA:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL.
DR   GO; GO:0034341; P:response to type II interferon; ISS:BHF-UCL.
DR   GO; GO:0002309; P:T cell proliferation involved in immune response; ISS:BHF-UCL.
DR   GO; GO:0007035; P:vacuolar acidification; ISS:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; ISS:BHF-UCL.
DR   HAMAP; MF_00221; NRAMP; 1.
DR   InterPro; IPR001046; NRAMP_fam.
DR   PANTHER; PTHR11706:SF52; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; 1.
DR   PANTHER; PTHR11706; SOLUTE CARRIER PROTEIN FAMILY 11 MEMBER; 1.
DR   Pfam; PF01566; Nramp; 1.
DR   PRINTS; PR00447; NATRESASSCMP.
DR   TIGRFAMs; TIGR01197; nramp; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Glycoprotein; Ion transport; Iron; Iron transport;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..550
FT                   /note="Natural resistance-associated macrophage protein 1"
FT                   /id="PRO_0000212588"
FT   TOPO_DOM        1..58
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        59..76
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        77..85
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        86..105
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        106..142
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        143..163
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        164..167
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        168..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        188..196
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        197..217
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        218..240
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..259
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..287
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..307
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        308..349
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        350..369
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        370..400
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        401..418
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        419..429
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        430..450
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        451..466
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        467..488
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        489..496
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        497..516
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        517..550
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..25
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        338
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..13
FT                   /note="MTGDKGPQRLSGS -> MVRCQLTATSTSQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047875"
FT   VAR_SEQ         14..131
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047876"
FT   VARIANT         30
FT                   /note="Q -> R (in dbSNP:rs751872662)"
FT                   /id="VAR_004629"
FT   VARIANT         318
FT                   /note="A -> V (in dbSNP:rs201565523)"
FT                   /evidence="ECO:0000269|PubMed:7717395"
FT                   /id="VAR_004630"
FT   VARIANT         543
FT                   /note="D -> N (associated with susceptibility to infection
FT                   with Mycobacterium ulcerans; dbSNP:rs17235409)"
FT                   /evidence="ECO:0000269|PubMed:7717395"
FT                   /id="VAR_004631"
FT   CONFLICT        54
FT                   /note="S -> R (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        84
FT                   /note="A -> L (in Ref. 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="A -> P (in Ref. 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        275
FT                   /note="A -> V (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="V -> A (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        315
FT                   /note="N -> K (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        397
FT                   /note="R -> S (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        441
FT                   /note="F -> V (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        478
FT                   /note="A -> T (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        544
FT                   /note="Q -> H (in Ref. 8; CAA57541)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   550 AA;  59872 MW;  AA670763D52EEECC CRC64;
     MTGDKGPQRL SGSSYGSISS PTSPTSPGPQ QAPPRETYLS EKIPIPDTKP GTFSLRKLWA
     FTGPGFLMSI AFLDPGNIES DLQAGAVAGF KLLWVLLWAT VLGLLCQRLA ARLGVVTGKD
     LGEVCHLYYP KVPRTVLWLT IELAIVGSDM QEVIGTAIAF NLLSAGRIPL WGGVLITIVD
     TFFFLFLDNY GLRKLEAFFG LLITIMALTF GYEYVVARPE QGALLRGLFL PSCPGCGHPE
     LLQAVGIVGA IIMPHNIYLH SALVKSREID RARRADIREA NMYFLIEATI ALSVSFIINL
     FVMAVFGQAF YQKTNQAAFN ICANSSLHDY AKIFPMNNAT VAVDIYQGGV ILGCLFGPAA
     LYIWAIGLLA AGQSSTMTGT YAGQFVMEGF LRLRWSRFAR VLLTRSCAIL PTVLVAVFRD
     LRDLSGLNDL LNVLQSLLLP FAVLPILTFT SMPTLMQEFA NGLLNKVVTS SIMVLVCAIN
     LYFVVSYLPS LPHPAYFGLA ALLAAAYLGL STYLVWTCCL AHGATFLAHS SHHHFLYGLL
     EEDQKGETSG
//
